Literature DB >> 29980839

Malignant invasion of the central nervous system: the hidden face of a poorly understood outcome of prostate cancer.

Eliane Gouvêa de Oliveira Barros1, Nathalia Meireles Da Costa2, Celia Yelimar Palmero3, Luis Felipe Ribeiro Pinto2, Luiz Eurico Nasciutti3, Antonio Palumbo4,5.   

Abstract

Malignancies of the central nervous system include primary brain tumors and brain metastases, the latter being the major cause of intracranial neoplasms in adults. Although prostate cancer (PCa) brain metastases are not the most common source, recent data show that the relevance of prostate cancer brain metastases (PCBM) cannot be neglected. In this review, we focus on the molecular repertory as well as on the phenotypical similarities between PCBM and primary PCa, such as the cellular evolution and the maintenance of androgen-receptor expression. Moreover, the simultaneous occurrence of PCBM with other PCa metastatic sites and the significance of the clinical heterogeneity of the disease are also discussed. In addition, a potential relationship between the heterogeneous behavior exhibited by PCBM and the co-occurrence of malignant cell clusters with distinct genetic profiles is also hypothesized, as well as the prominent role of astrocytes in the establishment of PCBM.

Entities:  

Keywords:  Astrocytes; Brain metastasis; Microenvironment; Prostate cancer; Prostate cancer brain metastases

Mesh:

Substances:

Year:  2018        PMID: 29980839     DOI: 10.1007/s00345-018-2392-6

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  123 in total

Review 1.  Astrocyte dysfunction in neurological disorders: a molecular perspective.

Authors:  Gerald Seifert; Karl Schilling; Christian Steinhäuser
Journal:  Nat Rev Neurosci       Date:  2006-03       Impact factor: 34.870

Review 2.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 3.  Reactive astrocytes: cellular and molecular cues to biological function.

Authors:  J L Ridet; S K Malhotra; A Privat; F H Gage
Journal:  Trends Neurosci       Date:  1997-12       Impact factor: 13.837

4.  Prostate cancer presenting as visual changes.

Authors:  Karin B Olson; Kenneth J Pienta
Journal:  Anticancer Res       Date:  2006 Jan-Feb       Impact factor: 2.480

5.  Intracranial metastasis of adenocarcinoma of the prostate presenting with symptoms of spinal cord compression.

Authors:  Rachael Hutton; John Maguire; Tarik Amer; John Fitzpatrick; Rami Hasan; Mark Ablett; Robert Meddings
Journal:  Indian J Surg       Date:  2014-07-23       Impact factor: 0.656

Review 6.  Intermittent vs Continuous Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-analysis.

Authors:  Sindy Magnan; Ryan Zarychanski; Laurie Pilote; Laurence Bernier; Michèle Shemilt; Eric Vigneault; Vincent Fradet; Alexis F Turgeon
Journal:  JAMA Oncol       Date:  2015-12       Impact factor: 31.777

Review 7.  Adhesion molecule expression and regulation on cells of the central nervous system.

Authors:  S J Lee; E N Benveniste
Journal:  J Neuroimmunol       Date:  1999-08-03       Impact factor: 3.478

8.  Detection of brain metastasis with 68Ga-labeled PSMA ligand PET/CT: a novel radiotracer for imaging of prostate carcinoma.

Authors:  Partha Sarathi Chakraborty; Rajiv Kumar; Madhavi Tripathi; Chandan Jyoti Das; Chandrasekhar Bal
Journal:  Clin Nucl Med       Date:  2015-04       Impact factor: 7.794

9.  Distant metastases from prostatic carcinoma express androgen receptor protein.

Authors:  A Hobisch; Z Culig; C Radmayr; G Bartsch; H Klocker; A Hittmair
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

Review 10.  The metastatic cascade in prostate cancer.

Authors:  Manit Arya; Simon R Bott; Iqbal S Shergill; Hashim U Ahmed; Magali Williamson; Hiten R Patel
Journal:  Surg Oncol       Date:  2006-12-05       Impact factor: 3.279

View more
  3 in total

1.  Intracranial Metastasis from Prostate Cancer: Investigation, Incidence, and Imaging Findings in a Large Cohort of Australian Men.

Authors:  Rhiannon McBean; Annaleis Tatkovic; David Chee Wong
Journal:  J Clin Imaging Sci       Date:  2021-04-24

2.  Combined Naïve Bayesian, Chemical Fingerprints and Molecular Docking Classifiers to Model and Predict Androgen Receptor Binding Data for Environmentally- and Health-Sensitive Substances.

Authors:  Alfonso T García-Sosa; Uko Maran
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

3.  Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage.

Authors:  Ding-Fang Zhang; Zhi-Chun Yang; Jian-Qiang Chen; Xiang-Xiang Jin; Yin-da Qiu; Xiao-Jing Chen; Hong-Yi Shi; Zhi-Guo Liu; Min-Shan Wang; Guang Liang; Xiao-Hui Zheng
Journal:  BMC Complement Med Ther       Date:  2021-07-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.